Bookbot

Routledge Studies in Innovation, Organization and Technology - 35: Business Modeling for Life Science and Biotech Companies

Creating Value and Competitive Advantage with the Milestone Bridge

Zapisz

Parametry

  • 212 stron
  • 8 godzin czytania

Więcej o książce

Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.

Zakup książki

Routledge Studies in Innovation, Organization and Technology - 35: Business Modeling for Life Science and Biotech Companies, Alberto Onetti, Antonella Zucchella

Język
Rok wydania
2018
Oprawa
(miękka),
Stan książki
Dobry
Cena
199,99 zł

Metody płatności

Nikt jeszcze nie ocenił.Oceń

Tytuł
Routledge Studies in Innovation, Organization and Technology - 35: Business Modeling for Life Science and Biotech Companies
Podtytuł
Creating Value and Competitive Advantage with the Milestone Bridge
Język
angielski
Wydawca
Routledge
Rok wydania
2018
Oprawa
miękka
Liczba stron
212
ISBN10
1138616907
ISBN13
9781138616905
Seria
Opis
Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.